149 related articles for article (PubMed ID: 31791181)
21. Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.
Mende R; Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Lin E; Chang J; Hoi AY; Morand EF; Harris J; Lang T
Front Immunol; 2018; 9():1250. PubMed ID: 29930551
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3
Marinho A; Carvalho C; Boleixa D; Bettencourt A; Leal B; Guimarães J; Neves E; Oliveira JC; Almeida I; Farinha F; Costa PP; Vasconcelos C; Silva BM
Immunol Res; 2017 Feb; 65(1):197-206. PubMed ID: 27423437
[TBL] [Abstract][Full Text] [Related]
23. The relation of interleukin 17 (IL-17) and IL-23 to Th1/Th2 cytokines and disease activity in systemic lupus erythematosus.
Mok MY; Wu HJ; Lo Y; Lau CS
J Rheumatol; 2010 Oct; 37(10):2046-52. PubMed ID: 20682672
[TBL] [Abstract][Full Text] [Related]
24. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
25. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
[TBL] [Abstract][Full Text] [Related]
26. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters.
Bogaczewicz J; Sysa-Jedrzejowska A; Arkuszewska C; Zabek J; Kontny E; McCauliffe D; Wozniacka A
Lupus; 2012 Apr; 21(5):477-84. PubMed ID: 22065093
[TBL] [Abstract][Full Text] [Related]
28. Diminished IL-17A levels may protect filarial-infected individuals from development of rheumatoid arthritis and systemic lupus erythematosus.
Panda AK; Das BK
Lupus; 2017 Apr; 26(4):348-354. PubMed ID: 27488471
[TBL] [Abstract][Full Text] [Related]
29. The star target in SLE: IL-17.
Yang Y; Yan C; Yu L; Zhang X; Shang J; Fan J; Zhang R; Ren J; Duan X
Inflamm Res; 2023 Feb; 72(2):313-328. PubMed ID: 36538077
[TBL] [Abstract][Full Text] [Related]
30. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
[TBL] [Abstract][Full Text] [Related]
31. IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus.
Geginat J; Vasco M; Gerosa M; Tas SW; Pagani M; Grassi F; Flavell RA; Meroni P; Abrignani S
Semin Immunol; 2019 Aug; 44():101330. PubMed ID: 31735515
[TBL] [Abstract][Full Text] [Related]
32. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
33. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
34. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
De la Cruz-Mosso U; García-Iglesias T; Bucala R; Estrada-García I; González-López L; Cerpa-Cruz S; Parra-Rojas I; Gámez-Nava JI; Pérez-Guerrero EE; Muñoz-Valle JF
Cell Immunol; 2018 Feb; 324():42-49. PubMed ID: 29397904
[TBL] [Abstract][Full Text] [Related]
35. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
36. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.
Peng H; Wang W; Zhou M; Li R; Pan HF; Ye DQ
Clin Rheumatol; 2013 Sep; 32(9):1255-66. PubMed ID: 23708831
[TBL] [Abstract][Full Text] [Related]
37. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
38. IL-17-producing T cells in lupus nephritis.
Apostolidis SA; Crispín JC; Tsokos GC
Lupus; 2011 Feb; 20(2):120-4. PubMed ID: 21303828
[TBL] [Abstract][Full Text] [Related]
39. Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus.
An N; Chen Y; Wang C; Yang C; Wu ZH; Xue J; Ye L; Wang S; Liu HF; Pan Q
Cell Physiol Biochem; 2017; 44(1):412-422. PubMed ID: 29141242
[TBL] [Abstract][Full Text] [Related]
40. TLR4
Ma K; Li J; Wang X; Lin X; Du W; Yang X; Mou F; Fang Y; Zhao Y; Hong X; Chan KW; Zhang X; Liu D; Sun L; Lu L
Ann Rheum Dis; 2018 Oct; 77(10):1498-1506. PubMed ID: 29925508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
